Approved yesterday by the FDA, Trelegy Ellipta is the first ever daily single-inhaler to combine a triple therapy for COPD, and could ... GSK's newer double therapy, Breo Ellipta, which is slowly ...

The drug, known as Breo Ellipta in the US, has already disappointed in one pivotal study. The Summit trial, published 12 months ago, showed the drug failed to cut the risk of death in COPD ...

GSK plc GSK reported fourth-quarter 2024 core earnings of 59 cents per American depositary share (ADS), which beat the Zacks ...

The demand for inhalation and nasal spray generic drugs is growing as these medications provide affordable and effective treatment options for respiratory ailments like asthma, COPD, and allergies.

A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a lawsuit filed by his family. Cole Schmidtknecht, 22, suffered from asthma ...

That didn’t deter him, though, and his band Inhaler have been vindicating that decision ever since the release of their lockdown-delayed 2021 debut album. Ignoring the advice of his parents ...

As for Inhaler, ‘Open Wide’ was shared today (February 7) and followed yesterday’s release of the final single ‘Billy (Yeah Yeah Yeah)’. “We’ve definitely gotten better at writing songs.

The report found a rise in visits related to burn and eye injuries. The percentage of emergency department (ED) visits related to fire and smoke inhalation rose dramatically in the days ...

Objective: To review the basis for the estimated comparative daily dosages of inhaled corticosteroids for children and adults that are presented in the National Heart, Lung, and Blood Institute's ...

In today's fast-paced world, many individuals struggle with respiratory issues, whether due to chronic conditions like asthma ...

Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

A Wisconsin family is suing Walgreens and OptumRx after a sudden inhaler price hike from $66 to $539 forced their son to forgo his medication, leading to a fatal asthma attack. Listen to Story Family ...